Drug Designing: Open Access
Open Access

ISSN: 2169-0138

Drug Designing: Open Access : Citations & Metrics Report

Articles published in Drug Designing: Open Access have been cited by esteemed scholars and scientists all around the world. Drug Designing: Open Access has got h-index 9, which means every article in Drug Designing: Open Access has got 9 average citations.

Following are the list of articles that have cited the articles published in Drug Designing: Open Access.

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012
Total published articles	22	32	30	31	67	2	5	16	18	12	14	24	6
Research, Review articles and Editorials	0	2	2	24	33	0	4	15	15	12	10	25	6
Research communications, Review communications, Editorial communications, Case reports and Commentary	14	30	27	7	35	2	1	1	3	0	4	3	0
Conference proceedings	0	5	5	0	0	0	124	81	41	56	0	0	58
Citations received as per Google Scholar, other indexing platforms and portals	45	51	54	62	43	41	41	23	48	16	10	5	0

Journal total citations count	456
Journal impact factor	1.70
Journal 5 years impact factor	1.5
Journal cite score	1.57
Journal h-index	9
Journal h-index since 2019	7

Important citations (297)

Advancements in novel drug delivery systems and opportunities for indian pharmaceutical companies View at Publisher View at Google Scholar View at Indexing
Design, synthesis, characterization and in vitro kinetic study of novel antibacterials prodrugs View at Publisher View at Google Scholar View at Indexing
Antibacterial predrugs-from 1899 till 2015 View at Publisher View at Google Scholar View at Indexing
Nanotechnology: a potential tool in exploring herbal benefits View at Publisher View at Google Scholar View at Indexing
Antibacterial activity of novel prodrugs of amoxicillin and cephalexin View at Publisher View at Google Scholar View at Indexing
Diclofenac codrugs and prodrugs-three decades of design View at Publisher View at Google Scholar View at Indexing
A solution to aversive tasting drugs for pediatric and geriatric patients View at Publisher View at Google Scholar View at Indexing
Enzyme models-from catalysis to prodrugs View at Publisher View at Google Scholar View at Indexing
Prodrug design vs. drug design View at Publisher View at Google Scholar View at Indexing
Computationally designed prodrugs of statins based on kirby’s enzyme model View at Publisher View at Google Scholar View at Indexing
Prodrugs for masking the bitter taste of drugs View at Publisher View at Google Scholar View at Indexing
Physicochemical property trends of marketed prodrugs View at Publisher View at Google Scholar View at Indexing
Prodrugs design based on inter? and intramolecular chemical processes View at Publisher View at Google Scholar View at Indexing
The prodrug naming dilemma View at Publisher View at Google Scholar View at Indexing
From idea to market: the drug design, development & approval process View at Publisher View at Google Scholar View at Indexing
Drug discovery: concepts and approaches View at Publisher View at Google Scholar View at Indexing
Four new diterpenoids from isodon eriocalyx var. laxiflora View at Publisher View at Google Scholar View at Indexing
Ent-kauranoids isolated from isodon eriocalyx var. laxiflora and their structure activity relationship analyses View at Publisher View at Google Scholar View at Indexing
Laxiflorol a, the first example of 7,8:15,16-di-seco-15-nor-21-homo-ent-kauranoid from isodon eriocalyx var. laxiflora View at Publisher View at Google Scholar View at Indexing
Fast dissolving drug delivery system: a review View at Publisher View at Google Scholar View at Indexing
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next »

Top